Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema
Trial details
- Registry ID
- NCT06825702
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular EdemaNCT06825702 | KPRX | Phase 2 | Recruiting | 2026-11Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |